J. Bell

发表

Architectural Protein Subclasses Shape 3D Organization of Genomes during Lineage Commitment

Jennifer E. Phillips-Cremins, James Taylor, J. Dekker, 2013, Cell.

Factors affecting the persistence of drug-induced reprogramming of the cancer methylome

J. Kowalski, M. T. McCabe, B. Barwick, 2016, Epigenetics.

Abstract PR08: GC skew defines distinct RNA polymerase pause sites in CpG island promoters

Wendy A. Kellner, P. Vertino, J. S. Bell, 2016 .

Orphan CpG islands define a novel class of highly active enhancers

P. Vertino, J. S. Bell, J. Bell, 2017, Epigenetics.

Galactic Cosmic Radiation Induces Persistent Epigenome Alterations Relevant to Human Lung Cancer

K. Conneely, H. Feng, J. Kowalski, 2018, Scientific Reports.

Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort

Bonnie V. Dougherty, N. Beaubier, T. Taxter, 2021, BMC Cancer.

Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer

Frederick M. Howard, O. Olopade, R. Nanda, 2023, JAMA network open.

Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds.

Margaret A. Johns, D. Urban, A. Jadhav, 2016, Cell chemical biology.

Epigenetically heterogeneous tumor cells direct collective invasion through filopodia-driven fibronectin micropatterning

J. Konen, A. Marcus, J. Kowalski, 2020, Science Advances.

Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data.

M. Stumpe, R. Pe Benito, N. Beaubier, 2020, Clinical breast cancer.

Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations

Frederick M. Howard, K. White, F. M. De La Vega, 2023, Breast Cancer Research.

Transcriptome-based cancer type prediction for tumors of unknown origin.

K. White, T. Taxter, Raphael A. Pelossof, 2019, Journal of Clinical Oncology.

Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort

Bonnie V. Dougherty, N. Beaubier, T. Taxter, 2022, BMC Cancer.

Real-world Evidence of Diagnostic Testing and Treatment Patterns in U.S. Breast Cancer Patients with Implications for Treatment Biomarkers from RNA-sequencing Data

M. Stumpe, R. Pe Benito, N. Beaubier, 2020, medRxiv.

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

S. Loi, M. Burkard, R. Bose, 2023, Annals of Oncology.

An integrative molecular framework to predict homologous recombination deficiency.

K. White, A. Venkat, Jerod Parsons, 2020 .

Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds.

Margaret A. Johns, D. Urban, A. Jadhav, 2016, Cell chemical biology.

Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort

Bonnie V. Dougherty, N. Beaubier, T. Taxter, 2021, BMC Cancer.

Abstract 2239: Comprehensive validation of RNA sequencing for clinical NGS fusion genes and RNA expression reporting

N. Beaubier, Jerod Parsons, C. Igartua, 2021, Molecular and Cellular Biology/Genetics.

Abstract 5466: Robust detection of sequencing batch effects in RNA through low dimensional embedding with subtype-matched reference samples

K. White, C. Igartua, Calvin McCarter, 2020, Clinical Research (Excluding Clinical Trials).